{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:15:31Z","timestamp":1788344131908,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1053\/j.seminhematol.2016.07.001","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T09:34:58Z","timestamp":1469525698000},"page":"252-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Haploidentical transplants using ex vivo T-cell depletion"],"prefix":"10.1053","volume":"53","author":[{"given":"Massimo F.","family":"Martelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Aversa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1053\/j.seminhematol.2016.07.001_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM198509263131301","article-title":"Marrow transplantation from related donors other than HLA-identical siblings","volume":"313","author":"Beatty","year":"1985","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.seminhematol.2016.07.001_bib2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/00007890-198743060-00014","article-title":"Graft rejection in recipients of T cell depleted HLA-nonidentical marrow transplants for leukemia: identification of host derived anti-donor allocytotoxic T lymphocytes","volume":"43","author":"Kernan","year":"1987","journal-title":"Transplantation"},{"issue":"7","key":"10.1053\/j.seminhematol.2016.07.001_bib3","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V73.7.2025.2025","article-title":"Enhancement by dimethyl myleran of donor-type chimerism in murine recipients of bone marrow allografts","volume":"73","author":"Lapidot","year":"1989","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.001_bib4","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/nm1295-1268","article-title":"Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice","volume":"1","author":"Bachar-Lusting","year":"1995","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2016.07.001_bib5","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V84.11.3948.bloodjournal84113948","article-title":"Successful engraftment of T-cell-depleted haploidentical \"three-loci\" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum","volume":"84","author":"Aversa","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.001_bib6","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1053\/j.seminhematol.2016.07.001_bib7","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1053\/j.seminhematol.2016.07.001_bib8","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1182\/blood-2008-02-140095","volume":"112","author":"Ciceri","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.001_bib9","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2016.07.001_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood-2006-07-038687","article-title":"Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value","volume":"110","author":"Ruggeri","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.001_bib11","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.coi.2004.07.010","article-title":"Killer immunoglobulin-like receptors","volume":"16","author":"Moretta","year":"2004","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"10.1053\/j.seminhematol.2016.07.001_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/MOH.0b013e3283590395","article-title":"Natural killer cell alloreactivity 10 years later","volume":"19","author":"Velardi","year":"2012","journal-title":"Curr Opin Hematol"},{"issue":"13","key":"10.1053\/j.seminhematol.2016.07.001_bib13","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1182\/blood-2005-05-1775","article-title":"Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation","volume":"106","author":"Perruccio","year":"2005","journal-title":"Blood"},{"issue":"20","key":"10.1053\/j.seminhematol.2016.07.001_bib14","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2016.07.001_bib15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/CJI.0b013e31817b9c6b","article-title":"T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical donors","volume":"31","author":"Comoli","year":"2008","journal-title":"J Immunother"},{"issue":"19","key":"10.1053\/j.seminhematol.2016.07.001_bib16","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2009-07-232454","article-title":"Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation","volume":"114","author":"Leen","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminhematol.2016.07.001_bib17","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1182\/blood-2007-08-104471","article-title":"A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique","volume":"111","author":"Mielke","year":"2008","journal-title":"Blood"},{"issue":"21","key":"10.1053\/j.seminhematol.2016.07.001_bib18","first-page":"3020","article-title":"Reduction in incidence of severe infections by transplantation of high doses of haploidentical T cells selectively depleted of alloreactive units","volume":"118","author":"Roy","year":"2011","journal-title":"ASH Annual Meeting"},{"issue":"4","key":"10.1053\/j.seminhematol.2016.07.001_bib19","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1182\/blood-2002-08-2351","article-title":"Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation","volume":"101","author":"Marktel","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2016.07.001_bib20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/14653240510018136","article-title":"Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation","volume":"7","author":"Ciceri","year":"2005","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1053\/j.seminhematol.2016.07.001_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(09)70074-9","article-title":"Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study","volume":"10","author":"Ciceri","year":"2009","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1053\/j.seminhematol.2016.07.001_bib22","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1182\/blood-2012-01-405670","article-title":"T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation","volume":"120","author":"Vago","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2016.07.001_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.beha.2011.04.005","article-title":"Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3\/CD19 depleted stem cells","volume":"24","author":"Bader","year":"2011","journal-title":"Best Pract Res Clin Haematol"},{"issue":"8","key":"10.1053\/j.seminhematol.2016.07.001_bib24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1080\/14653240701644000","article-title":"A large-scale method for the selective depletion of alphabeta T lymphocytes from PBSC for allogeneic transplantation","volume":"9","author":"Chaleff","year":"2007","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1053\/j.seminhematol.2016.07.001_bib25","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/j.seminoncol.2012.09.007","article-title":"New approaches to graft engineering for haploidentical bone marrow transplantation","volume":"39","author":"Handgretinger","year":"2012","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminhematol.2016.07.001_bib26","first-page":"1005","article-title":"Transplantation of TcR {alpha}{beta}\/CD19 depleted stem cells from haploidentical donors: robust engraftment and rapid immune reconstitution in children with high risk leukemia","volume":"118","author":"Handgretinger","year":"2011","journal-title":"ASH Annual Meeting Abstracts"},{"issue":"5","key":"10.1053\/j.seminhematol.2016.07.001_bib27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nri797","article-title":"Gammadelta T cells: functional plasticity and heterogeneity","volume":"2","author":"Carding","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"1-2","key":"10.1053\/j.seminhematol.2016.07.001_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.imlet.2013.09.027","article-title":"Negative depletion of \u03b1\/\u03b2+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation","volume":"155","author":"Locatelli","year":"2013","journal-title":"Immunol Lett"},{"issue":"5","key":"10.1053\/j.seminhematol.2016.07.001_bib29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of \u03b1\u03b2+ T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.001_bib30","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood.V122.21.4609.4609","article-title":"Haploidentical stem cell transplantation after negative depletion of T cells expressing the \u03b1\u03b2 chain of the T-cell receptor (TCR) for adults with hematological malignancies","volume":"122","author":"Prezioso","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.001_bib31","article-title":"Ex vivo TCR\u03b1\/\u03b2\/CD19 T and B cell depletion in HSCT for treatment of adult patients with hematological disease","author":"Aversa","year":"2014","journal-title":"Milteni Symposium on Cellular therapy: Facts, developments, future visions, EBMT meeting, Milan"},{"issue":"3","key":"10.1053\/j.seminhematol.2016.07.001_bib32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.beha.2008.07.004","article-title":"Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation","volume":"21","author":"Rezvani","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"issue":"5","key":"10.1053\/j.seminhematol.2016.07.001_bib33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.coi.2009.07.015","article-title":"Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia","volume":"21","author":"Velardi","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"10.1053\/j.seminhematol.2016.07.001_bib34","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1182\/blood-2010-04-278317","article-title":"Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis","volume":"116","author":"Gupta","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2016.07.001_bib35","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2012-08-449108","article-title":"Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia","volume":"121","author":"Scaradavou","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminhematol.2016.07.001_bib36","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood-2015-04-639831","article-title":"Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia","volume":"126","author":"Ciurea","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2016.07.001_bib37","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"issue":"3","key":"10.1053\/j.seminhematol.2016.07.001_bib38","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/icb.2010.137","article-title":"Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns","volume":"89","author":"Miyara","year":"2011","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"10.1053\/j.seminhematol.2016.07.001_bib39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.20020399","article-title":"Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation","volume":"196","author":"Hoffmann","year":"2002","journal-title":"J Exp Med"},{"issue":"6","key":"10.1053\/j.seminhematol.2016.07.001_bib40","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1182\/blood-2006-08-044529","article-title":"In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation","volume":"109","author":"Nguyen","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2016.07.001_bib41","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood-2007-07-103895","article-title":"The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation","volume":"111","author":"Nguyen","year":"2008","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2016.07.001_bib42","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.V99.10.3493","article-title":"The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2016.07.001_bib43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1084\/jem.20020090","article-title":"CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease","volume":"196","author":"Cohen","year":"2002","journal-title":"J Exp Med"},{"issue":"9","key":"10.1053\/j.seminhematol.2016.07.001_bib44","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","article-title":"CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat Med"},{"issue":"11","key":"10.1053\/j.seminhematol.2016.07.001_bib45","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI17702","article-title":"Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia","volume":"112","author":"Trenado","year":"2003","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1053\/j.seminhematol.2016.07.001_bib46","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood-2014-03-564401","article-title":"HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse","volume":"124","author":"Martelli","year":"2014","journal-title":"Blood"},{"issue":"14","key":"10.1053\/j.seminhematol.2016.07.001_bib47","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2016.07.001_bib48","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1182\/blood-2013-10-531764","article-title":"\"Designed\" grafts for HLA-haploidentical stem cell transplantation","volume":"123","author":"Martelli","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminhematol.2016.07.001_bib49","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.4049\/jimmunol.0903781","article-title":"Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO","volume":"184","author":"Booth","year":"2010","journal-title":"J Immunol"},{"issue":"7350","key":"10.1053\/j.seminhematol.2016.07.001_bib50","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10160","article-title":"In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche","volume":"474","author":"Fujisaki","year":"2011","journal-title":"Nature"},{"issue":"8","key":"10.1053\/j.seminhematol.2016.07.001_bib51","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2016.07.001_bib52","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196316300506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196316300506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:24:45Z","timestamp":1758522285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196316300506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0037196316300506"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2016.07.001","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haploidentical transplants using ex vivo T-cell depletion","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2016.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}